Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
S. Ramakrishnan (Oxford, United Kingdom), D. Nicolau Jr (Oxford, United Kingdom), B. Langford (Oxford, United Kingdom), M. Mahdi (Oxford, United Kingdom), H. Jeffers (Oxford, United Kingdom), C. Mwasuku (Oxford, United Kingdom), K. Krassowska (Oxford, United Kingdom), R. Fox (Bicester, United Kingdom), I. Binnian (Eynsham, United Kingdom), V. Glover (Faringdon, United Kingdom), S. Bright (Witney, United Kingdom), C. Butler (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Matthews (Oxford, United Kingdom), L. Donnelly (London, United Kingdom), J. Simpson (Newcastle, New South Wales, Australia), J. Baker (London, United Kingdom), N. Fadai (Nottingham, United Kingdom), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), P. Barnes (London, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID
Session: ALERT: bronchiectasis and COVID
Session type: Clinical trials session
Number: 4270
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ramakrishnan (Oxford, United Kingdom), D. Nicolau Jr (Oxford, United Kingdom), B. Langford (Oxford, United Kingdom), M. Mahdi (Oxford, United Kingdom), H. Jeffers (Oxford, United Kingdom), C. Mwasuku (Oxford, United Kingdom), K. Krassowska (Oxford, United Kingdom), R. Fox (Bicester, United Kingdom), I. Binnian (Eynsham, United Kingdom), V. Glover (Faringdon, United Kingdom), S. Bright (Witney, United Kingdom), C. Butler (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Matthews (Oxford, United Kingdom), L. Donnelly (London, United Kingdom), J. Simpson (Newcastle, New South Wales, Australia), J. Baker (London, United Kingdom), N. Fadai (Nottingham, United Kingdom), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), P. Barnes (London, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom). Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial. 4270
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Omalizumab in patients with moderate-to-severe persistent asthma poorly controlled on high-dose inhaled corticosteroids and long-acting beta-agonists: Results of a phase IIIb randomized controlled trial Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016
Budesonide versus prednisone in acute wheezing: randomized double-blinded controlled placebo study Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008
Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial Source: ERJ Open Res, 7 (3) 00255-2021; 10.1183/23120541.00255-2021 Year: 2021
Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial Source: Eur Respir J, 58 (1) 2100130; 10.1183/13993003.00130-2021 Year: 2021
Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma Source: Eur Respir J 2016; 47: 981-984 Year: 2016
A multi-centre doubleblind randomised study examining the clinical outcome of treatment of the first asthma exacerbation with salmeterol xinafoate/fluticasone propionate combination product versus prednisolone Source: Eur Respir J 2003; 22: Suppl. 45, 287s Year: 2003
A randomised controlled trial of zafirlukast in acute asthma Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
Randomized controlled trial of nebulized budesonide suspension in acute severe exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002
Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial. Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Efficacy and safety of as-needed corticosteroid plus fast or short-acting beta-agonists monotherapy in patients with mild asthma: a meta-analysis of randomised controlled trials. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial Source: Eur Respir J, 57 (6) 2003338; 10.1183/13993003.03338-2020 Year: 2021
Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis. Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018